Rachel Humphrey

Insider Reports History

Location
C/O Mirati Therapeutics Inc., 4660 La Jolla Village Drive, Suite 500, San Diego, CA
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Rachel Humphrey
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rachel Humphrey:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Pyxis Oncology, Inc. Director Stock Option (Right to Buy) 37K $36.2K $0.98 Mar 31, 2025 Direct
Xilio Therapeutics, Inc. Director Common Stock 9.44K $7.84K $0.83 Oct 21, 2021 Direct

Insider Reports Filed by Rachel Humphrey

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PYXS Pyxis Oncology, Inc. Mar 31, 2025 1 $36.2K 4 Apr 2, 2025 Director
PYXS Pyxis Oncology, Inc. Mar 26, 2024 1 $0 4 Mar 28, 2024 Director
PYXS Pyxis Oncology, Inc. Mar 24, 2023 1 $0 4 Mar 28, 2023 Director
PYXS Pyxis Oncology, Inc. Aug 11, 2022 1 $0 4 Aug 15, 2022 Director
PYXS Pyxis Oncology, Inc. Aug 11, 2022 0 $0 3 Aug 15, 2022 Director
XLO Xilio Therapeutics, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 Director